Icahn School of Medicine at Mount Sinai
D

Safety Profile of Ruxolitinib in Patients With MF

By Icahn School of Medicine at Mount Sinai FEATURING Douglas Tremblay
By Icahn School of Medicine at Mount Sinai FEATURING Douglas Tremblay
857 views
September 29, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Recommended

24:08

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Indy Hematology Review

A. Tefferi

1.4K views

·

6 months ago
24:35

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

1.3K views

·

6 months ago
27:47

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Indy Hematology Review

S. Smith

656 views

·

6 months ago
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

883 views

·

7 months ago
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

414 views

·

1 month ago
37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey
08:18

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

901 views

·

10 months ago
16:18

Masterclasses from the Wards

Masterclasses in Dermatology

S. Elman

317 views

·

8 months ago
18:04

Momelotinib for Myelofibrosis: Top 10 Things You Should Know Post-FD…

Ruben Mesa

932 views

·

1 year ago
27:37

Review of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

2.7K views

·

1 year ago
06:00

Clinical Case Review: A Not-So-Sweet Case of Vulvar Ulceration

2024 Clinical Case Studies

A. Geisler

619 views

·

8 months ago
16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
06:18

SIMPLIFY-2 Trial: Momelotinib Vs. Continued Ruxolitinib or Best Avai…

Cleveland Clinic Taussig Cancer Institute

A. Gerds

302 views

·

4 months ago
29:26

Practice-Changing Updates in DLBCL and HL

Massachusetts General Hospital Cancer Center

J. Erika Haydu

304 views

·

5 months ago
17:07

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their Mana…

2024 ASCO® Annual Meeting Insights Hub

M. Minnema

282 views

·

5 months ago
16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
31:12

Practice-Changing Abstracts in NHL and HL From ASH 2023

UChicago Medicine

S. Smith

400 views

·

8 months ago
25:22

Treatment Updates and Management of Non-Hodgkin Lymphomas

Integrity CE

D. Wallace, M. Cortese

98 views

·

3 months ago
20:15

Current and Future Treatment Landscape of Myelofibrosis

XV Eurasian Hematology-Oncology Congress - EHOC 2024

R. Komrokji

138 views

·

1 month ago
40:38

Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …

UChicago Medicine

G. Venkataraman, A. Perry, K. Cahill, A. Akmatbekov, L. Wu

244 views

·

4 months ago
AUTOPLAY